Global Digital Therapeutics Market to Reach Valuation of USD 36.47 Billion by 2032 | Astute Analytica [Yahoo! Finance]
Akili, Inc. (AKLI)
Company Research
Source: Yahoo! Finance
This sector's expansion emphasizes its potential to significantly improve clinical outcomes and offer economic advantages New Delhi, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Global digital therapeutics market was valued at US$ 5.66 billion in 2023 and is projected to surpass the market size of US$ 36.47 billion by 2032 at a CAGR of 23.0% during the forecast period of 2024-2032. Digital therapeutics (DTx) are emerging as a transformative force in healthcare, signaling a shift from traditional pharmaceutical approaches to digital, non-pharmaceutical interventions aimed at behavior modification and enhancing overall health. These advancements suggest a move towards a more holistic health paradigm by 2025, emphasizing predictive, preventative, personalized, and participatory care. This evolution is showcased by rapid technological advances, including AI and epigenetics, alongside a societal shift towards a more engaged and personalized healthcare approach. The adoption of wearables and healt
Show less
Read more
Impact Snapshot
Event Time:
AKLI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKLI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKLI alerts
High impacting Akili, Inc. news events
Weekly update
A roundup of the hottest topics
AKLI
News
- Innosphere starts paediatric clinical trial for Novostim ADHD device [Yahoo! Finance]Yahoo! Finance
- Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial ResultsBusiness Wire
- Neurodivergence In The 21st Century: How Technology Supports Children's Potential [Forbes]Forbes
- Akili Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]Yahoo! Finance
AKLI
Sec Filings
- 4/30/24 - Form 8-K
- 4/23/24 - Form 8-K
- 3/12/24 - Form 4
- AKLI's page on the SEC website